AstraZeneca (AZN)
(Delayed Data from NSDQ)
$78.36 USD
+0.23 (0.29%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $78.35 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 26% (185 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.57 | 2.10 | 9.99 |
Current Quarter Estimate | 1.05 | 37.64 | 61.00 |
Year Ago Quarter Estimate | 0.87 | 11.39 | 54.84 |
Next Quarter Estimate | 1.06 | 34.85 | 63.00 |
Next Year Estimate | 4.69 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.74 | -0.80 | 15.67 |
Next Year | 16.67 | 15.80 | 9.31 |
Last 5 Years | 14.00 | 2.90 | 8.10 |
Next 5 Years | 13.60 | 13.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 21.58 | 15.53 |
Price/Book (MRQ) | 6.12 | 5.91 |
Price/Cash Flow (MRFY) | 14.48 | 11.11 |
Dividend Yield | 2.47% | 2.37% |
Net Profit Margin (TTM) | 13.11% | 40.05% |
Return on Equity (TTM) | 29.34% | 35.68% |
Debt to Equity (MRQ) | 0.69 | 31.94 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.